×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CC – chemours company (the) (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
12:35 pm
cc
Hydrofluoric Acid Industry to Grow at a 4% CAGR Through 2034, Driven by Expanding Polymer Applications | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Hydrofluoric Acid Industry to Grow at a 4% CAGR Through 2034, Driven by Expanding Polymer Applications | Future Market Insights, Inc. [Yahoo! Finance]
11/15
11:07 am
cc
Polytetrafluoroethylene (PTFE) Market Size Will Estimated to Excess at a CAGR of 3.6 % by 2034 | Transparency Market Research Inc [Yahoo! Finance]
Low
Report
Polytetrafluoroethylene (PTFE) Market Size Will Estimated to Excess at a CAGR of 3.6 % by 2034 | Transparency Market Research Inc [Yahoo! Finance]
11/13
04:30 pm
cc
The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033
Low
Report
The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033
11/13
09:00 am
cc
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033
Low
Report
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033
11/6
12:23 pm
cc
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $28.00 to $25.00. They now have an "outperform" rating on the stock.
Low
Report
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $28.00 to $25.00. They now have an "outperform" rating on the stock.
11/5
09:43 am
cc
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Morgan Stanley from $30.00 to $25.00. They now have an "equal weight" rating on the stock.
Low
Report
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Morgan Stanley from $30.00 to $25.00. They now have an "equal weight" rating on the stock.
11/5
09:43 am
cc
The Chemours Company (NYSE: CC) had its price target raised by analysts at Barclays PLC from $21.00 to $23.00. They now have an "equal weight" rating on the stock.
Low
Report
The Chemours Company (NYSE: CC) had its price target raised by analysts at Barclays PLC from $21.00 to $23.00. They now have an "equal weight" rating on the stock.
11/5
02:14 am
cc
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... [Yahoo! Finance]
Medium
Report
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
04:11 pm
cc
Form 4 Chemours Co For: Nov 15 Filed by: Cowan Alister
Low
Report
Form 4 Chemours Co For: Nov 15 Filed by: Cowan Alister
11/13
04:34 pm
cc
Form 8-K Chemours Co For: Nov 13
Low
Report
Form 8-K Chemours Co For: Nov 13
11/12
04:49 pm
cc
Form 4 Chemours Co For: Nov 07 Filed by: Scarborough Alvenia
Low
Report
Form 4 Chemours Co For: Nov 07 Filed by: Scarborough Alvenia
11/12
09:56 am
cc
Form SC 13G/A Chemours Co Filed by: FMR LLC
Low
Report
Form SC 13G/A Chemours Co Filed by: FMR LLC
11/6
03:45 pm
cc
Form 144 Chemours Co Filed by: Scarborough Alvenia
Low
Report
Form 144 Chemours Co Filed by: Scarborough Alvenia
11/4
06:42 am
cc
Form 10-Q Chemours Co For: Sep 30
Low
Report
Form 10-Q Chemours Co For: Sep 30
11/4
06:07 am
cc
Form 8-K Chemours Co For: Nov 04
High
Report
Form 8-K Chemours Co For: Nov 04
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/13
Q4/2019 12/31/2019 EPS 0.560 ZacksConsensus 0.430 ActVsEst 0.130 - Beat
23.5%
4/3 Form 8-K Chemours Co For: Apr 03 16.8%
4/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at Citigroup Inc from $10.00 to $8.00. They now have a "neutral" rating on the stock. 15.4%
3/13 Form DEF 14A Chemours Co For: Apr 28 12.7%
12/5 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Secu 11.1%
11/4 Q3/2019 9/30/2019 EPS 0.590 ZacksConsensus 0.560 ActVsEst 0.030 - Beat 10.8%
4/28 Chemours Announces Second Quarter Dividend 10.2%
3/25 Chemours Co (NYSE: CC) had its price target lowered by analysts at SunTrust Banks, Inc. from $19.00 to $10.00. They now have a "hold" rating on the stock. 9.1%
10/10 Investor Alert: Kaplan Fox Investigates The Chemours Company 7.1%
9/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at BMO Capital Markets from $31.00 to $23.00. They now have an "outperform" rating on the stock. 6.2%
4/3 Form 8-K Chemours Co For: Apr 03 16.8%
4/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at Citigroup Inc from $10.00 to $8.00. They now have a "neutral" rating on the stock. 15.4%
3/13 Form DEF 14A Chemours Co For: Apr 28 12.7%
12/5 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Secu 11.1%
11/4 Q3/2019 9/30/2019 EPS 0.590 ZacksConsensus 0.560 ActVsEst 0.030 - Beat 10.8%
4/28 Chemours Announces Second Quarter Dividend 10.2%
3/25 Chemours Co (NYSE: CC) had its price target lowered by analysts at SunTrust Banks, Inc. from $19.00 to $10.00. They now have a "hold" rating on the stock. 9.1%
10/10 Investor Alert: Kaplan Fox Investigates The Chemours Company 7.1%
9/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at BMO Capital Markets from $31.00 to $23.00. They now have an "outperform" rating on the stock. 6.2%
TOP News Decliners
8/1
Q2/2019 6/30/2019 EPS 0.720 ZacksConsensus 0.890 ActVsEst (0.170) - Miss
-19.1%
3/9 Chemours Inaugurates New World-Class Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science, Technology and Advanced Research Campus -13.4%
8/2 Chemours Buys Mining Operations Of Southern Ionics Minerals [Reuters] -8.1%
8/8 Form 4 Chemours Co For: Aug 07 Filed by: CRANSTON MARY B -8.0%
5/7 Carrier Transicold Europe Selects Chemours Opteon™ XL Refrigerant Family to Replace R-452A -7.9%
5/6 Chemours Co (NYSE: CC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -7.5%
4/15 Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call -7.1%
5/13 The Chemours Company's John Sworen To Be Awarded Gordon E. Moore Medal -6.9%
4/1 Chemours Co (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have a "sector perform" rating on the stock. -6.4%
9/30 Chemours Renews its Dedication to Sustainability, Issues Second Annual Corporate Responsibility Commitment Report -6.4%
3/9 Chemours Inaugurates New World-Class Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science, Technology and Advanced Research Campus -13.4%
8/2 Chemours Buys Mining Operations Of Southern Ionics Minerals [Reuters] -8.1%
8/8 Form 4 Chemours Co For: Aug 07 Filed by: CRANSTON MARY B -8.0%
5/7 Carrier Transicold Europe Selects Chemours Opteon™ XL Refrigerant Family to Replace R-452A -7.9%
5/6 Chemours Co (NYSE: CC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -7.5%
4/15 Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call -7.1%
5/13 The Chemours Company's John Sworen To Be Awarded Gordon E. Moore Medal -6.9%
4/1 Chemours Co (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have a "sector perform" rating on the stock. -6.4%
9/30 Chemours Renews its Dedication to Sustainability, Issues Second Annual Corporate Responsibility Commitment Report -6.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: